Antimicrobial Resistance and Therapeutic Discovery Training Program
抗菌素耐药性和治疗发现培训计划
基本信息
- 批准号:8852534
- 负责人:
- 金额:$ 18.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The challenge of drug-resistant microbes requires that a new generation of basic scientists be broadly trained and educated in anti-infective research so that a cadre of investigators will be available in the future to combat this global health problem. Coupled with the problem of resistance, this need is especially acute given the reduced number of new, effective antibiotics that have entered clinical practice in the past two decades. Thus, the objective of this new training grant at Emory University is to provide high quality training to a select group of highly motivated graduate students for careers as independent investigators in research on anti- infectives. The program will select three PhD candidates yearly from four graduate programs within the Graduate Division of Biological and Biomedical Sciences of Emory University for a two year period of training in the areas of antimicrobial resistance and therapeutic discovery. These graduate programs include faculty members from basic science and clinical departments of the School of Medicine, Emory College of Arts and Sciences and the Centers for Disease Control and Prevention (CDC). Educational training will consist of a course of study and programmatic events in sub-disciplines that emphasize research and education in anti-infective resistance and drug development; research training opportunities are provided in 25 laboratories with active research programs in these areas of research.
描述(由申请人提供):耐药微生物的挑战要求新一代基础科学家在抗感染研究方面接受广泛的培训和教育,以便将来能够有一批研究人员来应对这一全球健康问题。再加上耐药性问题,鉴于过去二十年进入临床实践的新型有效抗生素数量减少,这种需求尤为迫切。因此,埃默里大学这项新培训补助金的目标是为一批积极进取的研究生提供高质量的培训,以使其成为抗感染研究的独立研究者。该项目每年将从埃默里大学生物和生物医学科学研究生部的四个研究生项目中选拔三名博士生,接受为期两年的抗菌素耐药性和治疗发现领域的培训。这些研究生项目包括来自医学院基础科学和临床部门、埃默里艺术与科学学院以及疾病控制和预防中心 (CDC) 的教职人员。教育培训将包括子学科的学习课程和计划活动,强调抗感染耐药性和药物开发方面的研究和教育; 25 个实验室在这些研究领域开展了积极的研究项目,提供研究培训机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Maurice Shafer其他文献
William Maurice Shafer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Maurice Shafer', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10514632 - 财政年份:2020
- 资助金额:
$ 18.55万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10091811 - 财政年份:2020
- 资助金额:
$ 18.55万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10337023 - 财政年份:2020
- 资助金额:
$ 18.55万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
10646403 - 财政年份:2019
- 资助金额:
$ 18.55万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
10426304 - 财政年份:2019
- 资助金额:
$ 18.55万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
10201478 - 财政年份:2019
- 资助金额:
$ 18.55万 - 项目类别:
Function and regulation of the intrinsic antibiotic resistome of Neisseria gonorrhoeae
淋病奈瑟菌内在抗生素耐药性的功能和调控
- 批准号:
9982208 - 财政年份:2019
- 资助金额:
$ 18.55万 - 项目类别:
Gonococci: Genetics of Resistance to PMN Proteins
淋球菌:PMN 蛋白抗性遗传学
- 批准号:
9040074 - 财政年份:2015
- 资助金额:
$ 18.55万 - 项目类别:
Antimicrobial Resistance and Therapeutic Discovery Training Program
抗菌素耐药性和治疗发现培训计划
- 批准号:
8737434 - 财政年份:2014
- 资助金额:
$ 18.55万 - 项目类别:
Antimicrobial Resistance and Therapeutic Discovery Training Program
抗菌素耐药性和治疗发现培训计划
- 批准号:
10019072 - 财政年份:2014
- 资助金额:
$ 18.55万 - 项目类别:
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Research Grant
Non invasive methods to accelerate the development of injectable therapeutic depots
非侵入性方法加速注射治疗储库的开发
- 批准号:
EP/Z532976/1 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Research Grant
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Research Grant
Collaborative Research: CPS: Medium: Automating Complex Therapeutic Loops with Conflicts in Medical Cyber-Physical Systems
合作研究:CPS:中:自动化医疗网络物理系统中存在冲突的复杂治疗循环
- 批准号:
2322534 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Standard Grant
Uncovering the antimicrobial and antibiotic potentiating mechanism of acesulfame-K and maximising its topical therapeutic potential.
揭示安赛蜜的抗菌和抗生素增强机制并最大限度地发挥其局部治疗潜力。
- 批准号:
MR/Y001354/1 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Research Grant
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Collaborative R&D
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Launchpad
Analysis and quality control of novel mixed cell population for therapeutic development
用于治疗开发的新型混合细胞群的分析和质量控制
- 批准号:
10089851 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Collaborative R&D
Using patient-led genetics to identify new therapeutic targets in metastatic cholangiocarcinoma
利用患者主导的遗传学来确定转移性胆管癌的新治疗靶点
- 批准号:
EP/Y028546/1 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Fellowship














{{item.name}}会员




